Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208306
Company: LONG GROVE PHARMS
Company: LONG GROVE PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
METHADONE HYDROCHLORIDE | METHADONE HYDROCHLORIDE | 10MG/ML | INJECTABLE;INJECTION | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/27/2017 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208306Orig1s000ltr.pdf |
METHADONE HYDROCHLORIDE
INJECTABLE;INJECTION; 10MG/ML
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
METHADONE HYDROCHLORIDE | METHADONE HYDROCHLORIDE | 10MG/ML | INJECTABLE;INJECTION | Prescription | No | AP | 208306 | LONG GROVE PHARMS |
METHADONE HYDROCHLORIDE | METHADONE HYDROCHLORIDE | 10MG/ML | INJECTABLE;INJECTION | Prescription | Yes | AP | 021624 | MYLAN INSTITUTIONAL |